Zhang S - Search Results

1

Biological effects of IL-15 on immune cells and its potential for the treatment of cancer.

Zhang S, Zhao J, Bai X, Handley M, Shan F. Zhang S, et al. Int Immunopharmacol. 2021 Feb;91:107318. doi: 10.1016/j.intimp.2020.107318. Epub 2020 Dec 28. Int Immunopharmacol. 2021. PMID: 33383444 Review.

2

Chest Wall Toxicity After Stereotactic Body Radiation Therapy: A Pooled Analysis of 57 Studies.

Ma JT, Liu Y, Sun L, Milano MT, Zhang SL, Huang LT, Jing W, Zhao JZ, Han CB, Kong FS. Ma JT, et al. Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):843-850. doi: 10.1016/j.ijrobp.2018.11.036. Epub 2018 Nov 26. Int J Radiat Oncol Biol Phys. 2019. PMID: 30496884

3

Effects of Dynamin-related Protein 1 Regulated Mitochondrial Dynamic Changes on Invasion and Metastasis of Lung Cancer Cells.

Ma JT, Zhang XY, Cao R, Sun L, Jing W, Zhao JZ, Zhang SL, Huang LT, Han CB. Ma JT, et al. J Cancer. 2019 Jul 8;10(17):4045-4053. doi: 10.7150/jca.29756. eCollection 2019. J Cancer. 2019. PMID: 31417649 Free PMC article.

4

Durable Clinical Response to Pyrotinib After Resistance to Prior Anti-HER2 Therapy for HER2-Positive Advanced Gastric Cancer: A Case Report.

Huang LT, Ma JT, Zhang SL, Li XH, Sun L, Jing W, Zhao JZ, Wang YR, Han CB. Huang LT, et al. Front Oncol. 2019 Dec 20;9:1453. doi: 10.3389/fonc.2019.01453. eCollection 2019. Front Oncol. 2019. PMID: 31956604 Free PMC article.

5

The progress and confusion of anti-PD1/PD-L1 immunotherapy for patients with advanced non-small cell lung cancer.

Zhang S, Bai X, Shan F. Zhang S, et al. Int Immunopharmacol. 2020 Mar;80:106247. doi: 10.1016/j.intimp.2020.106247. Epub 2020 Jan 31. Int Immunopharmacol. 2020. PMID: 32007710 Review.

6

Impact of pulmonary interstitial lesions on efficacy and prognosis of EGFR-TKI-treated advanced non-small cell lung cancers.

Zhang XY, Cao R, Guo YJ, Zhen YH, Zheng JH, Huang LT, Zhang SL, Jing W, Sun L, Zhao JZ, Han CB, Ma JT. Zhang XY, et al. J Thorac Dis. 2020 Mar;12(3):839-848. doi: 10.21037/jtd.2019.12.128. J Thorac Dis. 2020. PMID: 32274151 Free PMC article.

7

Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A Review.

Guo Y, Song J, Wang Y, Huang L, Sun L, Zhao J, Zhang S, Jing W, Ma J, Han C. Guo Y, et al. Among authors: zhang s. Front Oncol. 2020 Dec 10;10:610923. doi: 10.3389/fonc.2020.610923. eCollection 2020. Front Oncol. 2020. PMID: 33363040 Free PMC article. Review.

8

Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials.

Sun L, Guo YJ, Song J, Wang YR, Zhang SL, Huang LT, Zhao JZ, Jing W, Han CB, Ma JT. Sun L, et al. Front Oncol. 2021 Jan 12;10:586596. doi: 10.3389/fonc.2020.586596. eCollection 2020. Front Oncol. 2021. PMID: 33511076 Free PMC article.

9

Rational Application of First-Line EGFR-TKIs Combined with Antiangiogenic Inhibitors in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Ma JT, Guo YJ, Song J, Sun L, Zhang SL, Huang LT, Jing W, Zhao JZ, Han CB. Ma JT, et al. Biomed Res Int. 2021 Jan 28;2021:8850256. doi: 10.1155/2021/8850256. eCollection 2021. Biomed Res Int. 2021. PMID: 33575349 Free PMC article.

10

Short-term outcomes and safety of radiotherapy for immediate breast reconstruction with autologous flap transfer following breast-conserving surgery.

Zhang SL, Song J, Wang YR, Guo YJ, Zhao JZ, Sun L, Huang LT, Ma JT, Han CB. Zhang SL, et al. BMC Cancer. 2021 Mar 2;21(1):214. doi: 10.1186/s12885-021-07915-4. BMC Cancer. 2021. PMID: 33653297 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82,903 results

Search Page

Filters